November 13th, 2026OT Roundup: GLP-1 NAION warning, LEMS clues, Eyedaptic Eva, AFibThe FDA adds a NAION warning to GLP-1 drugs, plus LEMS clues, Eyedaptic's new Eva AI assistant and a retinal imaging link to AFib.Read more
November 6th, 2026Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophyJayakrishna Ambati, MD, discusses phase 2 K8 results in GA, its inflammasome mechanism, and dosing designed for convenience.Read more
November 5th, 2026Global Summit for Eye Health 2026: Turning pledges into eye careHunter Cherwek, MD, of Orbis discusses summit commitments, eye care workforce training, and AI in low-resource settings.Read more
November 20th, 2026Why ST-100 is expanding from dry eye into corneal wound healingEric Schlumpf discusses why Stuart Therapeutics is taking vezocolmitide beyond dry eye disease and into corneal wound healing.Read more
November 19th, 2026Eichenbaum Acorns: Building the private academic model with Jeffrey S. Heier, MDFor Jeffrey S. Heier, MD, shaping retina trials, joining industry, and staying in clinic all rest on family and a strong team.Read more
November 18th, 2026The One Thing: Retinopathy’s slow slide, undetected blindness, innovation for all | Episode 7Patricio G. Schlottmann, MD, Nicholas J. Volpe, MD, and Hunter Cherwek, MD, point to retinopathy follow-up, missed diagnoses, and low-resource care.Read more
November 14th, 2026How Lambert-Eaton myasthenic syndrome presents around the eyesAlfredo A. Sadun, MD, PhD, explains how LEMS mimics myasthenia gravis around the eyes and why its cancer link matters.Read more
November 11th, 2026The One Thing: GA’s last frontier, the toll of ongoing care, back to glucose basics | Episode 6R. Ross Lakhanpal, MD, FACS, Anu Patel, MD, and Yasha S. Modi, MD, MHS, point to cell replacement in geographic atrophy, care burden, and glycemic control.Read more